Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy
CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer | BMC Cancer | Full Text
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19- 9 in Colorectal Cancer
Tumor markers - Cusabio
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19- 9 in Colorectal Cancer
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
CA 19-9 as a marker in addition to CEA to monitor colorectal cancer. | Semantic Scholar
CEA+CA19-9 in gastric cancer. Figure 3 CEA+CA19-9 in colon cancer. | Download Scientific Diagram
Frontiers | The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Raised Digestive Tumour Markers in Singapore - Dr Benjamin Yip
High preoperative serum CA 19-9 levels can predict poor oncologic outcomes in colorectal cancer patients on propensity score ana
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients
Nonenzymatic tumor markers of colorectal cancer applied in routine... | Download Table
CA 19-9 As a Marker in Addition to CEA to Monitor Colorectal Cancer - ScienceDirect
CA19-9 - Wikipedia
CA 19-9 As a Marker in Addition to CEA to Monitor Colorectal Cancer - ScienceDirect
Extremely high serum level of carbohydrate antigen 19-9 in a patient with colon adenocarcinoma
Colon cancer stage and tumor marker levels | Download Table
CA 19 .9 | RT Diagnostics
